Martin S, Dyer P A, Harris R, Manos J, Mallick N P, Gokal R, Johnson R W
Transplantation. 1985 Mar;39(3):256-8. doi: 10.1097/00007890-198503000-00008.
One of the most powerful influences on cadaveric renal graft survival is the enhancing effect of blood transfusions from unrelated individuals (1, 2). However, the optimum number of transfusions required to achieve this effect remains controversial. Enhanced graft survival following only one or two transfusions has been observed (3), although graft survival has also been found to be better for multitransfused recipients (4). Extrapolating from their studies on mice, Wood et al. (5) suggested that only a very small volume of blood may induce the transfusion effect in humans. As the number of transfusions increases so does the risk of sensitizing the patient to produce lymphocytotoxic antibodies that may impair the chances of the patient receiving a crossmatch-negative kidney graft (6, 7). Thus the problem is to minimize the chance of sensitization while still maintaining the beneficial effect of blood transfusion.
对尸体肾移植存活影响最大的因素之一是来自无关个体输血的增强作用(1,2)。然而,实现这种效果所需的最佳输血量仍存在争议。尽管多次输血的受者移植肾存活情况也较好(4),但有人观察到仅一两次输血后移植肾存活就得到了增强(3)。伍德等人(5)从小鼠研究中推断,在人类中可能只需极少量的血液就能诱导输血效应。随着输血量的增加,患者产生淋巴细胞毒性抗体致敏的风险也会增加,这可能会降低患者接受交叉配型阴性肾移植的机会(6,7)。因此,问题在于在尽量减少致敏几率的同时,仍保持输血的有益效果。